KLRS NASDAQ
Kalaris Therapeutics Inc
1W: -7.5%
1M: -30.8%
3M: -41.9%
YTD: -67.5%
1Y: -55.5%
$2.70
-0.15 (-5.26%)
Weekly Expected Move ±5.8%
$2
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-44M
Net Income
-105.4% YoY
$-46M
Free Cash Flow
-104.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-79.9%
ROA-46.0%
ROIC109.5%
Valuation
P/E-1.3
P/B1.1
EV/EBITDA-0.1
Leverage
Debt/Equity0.02
Current Ratio10.98
Interest Cov.0.0x
Quality Scores
Piotroski F0/9
Altman Z-1.62
Beneish M0.00